This post was originally published on this site
Here are the stocks in focus early in Wednesday’s trading session.
Reata Pharmaceuticals Inc.’s RETA stock was shooting up more than 170% in Wednesday morning action after the Food and Drug administration approved a drug treatment for Friedreich’s ataxia, a rare inherited disease that causes damage to the nervous system.
Shares of Sarepta…
